Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation
ID: 356169Type: Posted
Overview

Buyer

Centers for Disease Control - NCEZID (HHS-CDC-NCEZID)

Award Range

$75K - $100K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation" through a cooperative agreement aimed at enhancing educational resources for families affected by CJD. The initiative seeks to improve awareness and provide critical information regarding CJD, a rare and incurable brain disorder, by developing educational materials, organizing a national conference, and establishing a helpline for caregivers. With a total funding amount of $500,000 available over five years, eligible applicants include state and local governments, educational institutions, nonprofits, and for-profit organizations, with proposals due by March 18, 2025. For further inquiries, interested parties can contact Tracey Ponder at TPonder@cdc.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) of the CDC has issued a Notice of Funding Opportunity to improve educational support for families affected by Creutzfeldt-Jakob Disease (CJD). The program seeks to enhance resources and raise awareness about CJD, which is a rare and incurable brain disorder. The funding, totaling $500,000 over five years, is intended for various educational initiatives, including developing fact sheets, organizing a national conference, and establishing a toll-free helpline for caregivers and families. Eligible applicants include state and local governments, educational institutions, nonprofits, and for-profit organizations. Proposals must be submitted by March 18, 2025. The evaluation process involves an initial review of responsiveness and a merit review based on criteria such as background, evaluation plans, and organizational capacity. The primary goal is to provide necessary support and information to those impacted by CJD, facilitate national surveillance for the disease, and raise public awareness concerning prion diseases to foster early detection of emerging forms. This opportunity reflects the CDC's commitment to addressing public health challenges and improving the quality of life for patients and their families.
    Similar Opportunities
    Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Public Health Strategies to Address Alzheimer's Disease and Related Dementias," aimed at enhancing public health initiatives through cooperative agreements. This initiative seeks to support organizations in developing and implementing strategies that align with the National Healthy Brain Initiative Road Map, focusing on areas such as dementia risk reduction, early detection, and caregiver support. The funding opportunity is critical as Alzheimer's disease is a leading cause of death among older adults in the U.S., and the program aims to build evidence-based practices to improve brain health and support caregivers. Interested applicants can apply for one or more of the three components, with funding amounts ranging from $750,000 to $3 million, and must submit their applications by March 7, 2025. For further inquiries, contact Alisha Etheredge at BOLD@cdc.gov or call 770-488-7884.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.
    Improving well-being for individuals living with a blood disorder through evidence-based programs.
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control - NCBDDD is offering a federal grant opportunity aimed at improving the well-being of individuals living with blood disorders through evidence-based programs. The initiative seeks to enhance the emotional, social, and physical health of affected individuals by promoting mental health literacy and adapting programs that build psychosocial skills, ultimately aiming to reduce morbidity and improve quality of life. With an estimated total program funding of $5,925,000, the agency plans to award four cooperative agreements, with individual awards ranging from $135,000 to $450,000. Interested applicants can reach out to Dr. Fiona Bethea at gvu0@cdc.gov or by phone at 404-639-4033, with applications due by May 15, 2025, and awards expected to be announced by September 1, 2025.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Epilepsy Incidence Among Children in the United States
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Epilepsy Incidence Among Children in the United States," aimed at estimating the incidence of epilepsy among U.S. children aged 0 to 17 and identifying disparities influenced by demographic factors and social determinants of health. The initiative seeks to conduct a comprehensive study utilizing nationwide datasets to provide insights into epilepsy incidence, risk factors, and incidence disparities, thereby informing public health policies and resource allocation. With a total funding amount of $1.6 million available for a cooperative agreement over four years, the anticipated award for the first budget year is $500,000. Interested applicants, including small businesses and various organizations, must submit their applications by January 23, 2025, with a letter of intent due by December 12, 2024. For further inquiries, applicants can contact Natalie Brown at nbrown3@cdc.gov.
    Strengthening Vaccine-Preventable Disease Prevention and Response
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Strengthening Vaccine-Preventable Disease Prevention and Response," aimed at enhancing public health systems to improve vaccine access, confidence, and demand. This initiative continues the work of existing programs such as Vaccines for Children (VFC) and Section 317, focusing on achieving high vaccination coverage and responding effectively to vaccine-preventable disease outbreaks. The total funding available for this program is $2 billion over five years, with an expected 66 awards averaging over $6 million per budget period. Applications are due by March 13, 2025, and interested parties can contact Randi Tolstyk at KKQ9@cdc.gov for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    RFA-DD-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    Modeling Infectious Diseases in Healthcare (MInD Healthcare) to Improve Pathogen Prevention and Healthcare Delivery
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Modeling Infectious Diseases in Healthcare (MInD Healthcare) initiative, aimed at enhancing pathogen prevention and healthcare delivery through innovative mathematical modeling. The program seeks to develop computational tools to model the spread of healthcare-associated infections (HAIs) and antimicrobial-resistant organisms (AROs), predict outbreaks, and assess intervention strategies, with a focus on addressing health disparities among vulnerable populations. Eligible applicants include private institutions of higher education, with funding amounts ranging from $550,000 to $650,000, and a total estimated program funding of $19.5 million available for approximately six awards. Interested parties must submit their applications electronically by March 19, 2025, and can contact Nga Vuong at ypg2@cdc.gov for further information.